Search results for "Myc"

showing 10 items of 3773 documents

Anaplasma phagocytophilum Induces TLR- and MyD88-Dependent Signaling in In Vitro Generated Murine Neutrophils

2021

Anaplasma phagocytophilum is a tick-transmitted obligate intracellular Gram-negative bacterium that replicates in neutrophils. It elicits febrile disease in humans and in animals. In a mouse model, elimination of A. phagocytophilum required CD4+ T cells, but was independent of IFN-γ and other classical antibacterial effector mechanisms. Further, mice deficient for immune recognition and signaling via Toll-like receptor (TLR) 2, TLR4 or MyD88 were unimpaired in pathogen control. In contrast, animals lacking adaptor molecules of Nod-like receptors (NLR) such as RIP2 or ASC showed delayed clearance of A. phagocytophilum. In the present study, we investigated the contribution of further pattern…

0301 basic medicineMicrobiology (medical)ChemokineCLRanimal diseasesImmunologylcsh:QR1-502Microbiologylcsh:MicrobiologyNLR03 medical and health sciencesCellular and Infection Microbiology0302 clinical medicineImmune systemTLRparasitic diseasesNOD1cytokineddc:610ReceptorOriginal ResearchbiologychemokinefungiPattern recognition receptorSignal transducing adaptor proteinMyD88bacterial infections and mycosesbiology.organism_classificationAnaplasma phagocytophilumCell biologyiNOS030104 developmental biologyInfectious DiseasesTLR4biology.proteinbacteriaAnaplasma phagocytophilum030215 immunologyFrontiers in Cellular and Infection Microbiology
researchProduct

Fasciola hepatica eggs in paleofaeces of the Persian onager Equus hemionus onager, a donkey from Chehrabad archaeological site, dating back to the Sa…

2018

Fascioliasis is a highly pathogenic zoonotic disease caused by the liver trematodes Fasciola hepatica and F. gigantica. Within the multidisciplinary initiative against this disease, there is the aim of understanding how this disease reached a worldwide distribution, with important veterinary and medical repercussions, by elucidating the spreading steps followed by the two fasciolids from their paleobiogeograhical origins. Fasciola eggs were detected in paleofaeces of a donkey, probably the present-day endangered Persian onager Equus hemionus onager, found in the Chehrabad salt mine archaeological site, Zanjan province, northwestern Iran. The biological remains dated back to the Sassanid per…

0301 basic medicineMicrobiology (medical)Fascioliasis030231 tropical medicine610 Medicine & healthPersian onagerIranMicrobiology2726 Microbiology (medical)03 medical and health sciences0302 clinical medicine1311 GeneticsHepaticaparasitic diseasesGenetics1312 Molecular BiologyAnimalsDomesticationMolecular BiologyHistory AncientEcology Evolution Behavior and SystematicsMiddle EastFasciolabiologybusiness.industry2404 MicrobiologyEquidae2725 Infectious DiseasesFasciola hepatica030108 mycology & parasitologybiology.organism_classificationEquusArchaeologyHistory MedievalInfectious Diseases1105 Ecology Evolution Behavior and Systematics11294 Institute of Evolutionary MedicineLivestockDonkeybusiness
researchProduct

First phenotypic and genotypic description of Fasciola hepatica infecting highland cattle in the state of Mexico, Mexico

2018

Abstract Fascioliasis is a plantborne and zoonotic parasitic disease caused by fasciolid liver flukes. Fasciola hepatica is the only fasciolid species described in the Americas. Human fascioliasis endemic areas are mainly located in high altitude areas of the Americas. Given the necessity to characterize F. hepatica populations involved, the phenotypic and genotypic features of fasciolid adults infecting cattle in the highland area of Toluca, State of Mexico, Mexico, were analyzed and compared to fasciolid materials from the Northern Bolivian Altiplano, representing the altiplanic transmission pattern in a hyperendemic scenario. A computer image analysis system (CIAS) was applied on the bas…

0301 basic medicineMicrobiology (medical)FascioliasisGenotypeRange (biology)030231 tropical medicinebiology.animal_breedPopulationCattle DiseasesZoologyDNA RibosomalMicrobiology03 medical and health sciences0302 clinical medicineIntergenic regionHepaticaparasitic diseasesGeneticsAnimalsFasciola hepaticaGeography MedicaleducationMexicoMolecular BiologyRibosomal DNAEcology Evolution Behavior and SystematicsBase Compositioneducation.field_of_studybiologyHighland CattleFasciola hepatica030108 mycology & parasitologyLiver flukebiology.organism_classificationPhenotypeInfectious DiseasesHaplotypesCattleSequence AnalysisInfection, Genetics and Evolution
researchProduct

Subtle genotypic changes can be observed soon after diagnosis in Mycobacterium tuberculosis infection.

2016

Clonal variants of Mycobacterium tuberculosis (MTB) coexist in specific patients, although the dynamics of their emergence is unknown. We used MIRU-VNTR to detect microevolution leading to variants of MTB in 3 out of 19 patients (15%) soon after diagnosis (61-85 days). Most harbored SNPs and for some of them a potential functional role was suggested. Microevolution in tuberculosis seems to occur sooner and more often than expected and could affect tracking of transmission.

0301 basic medicineMicrobiology (medical)Functional roleAdultMaleTuberculosisGenotyping Techniques030106 microbiologyAdaptation BiologicalSingle-nucleotide polymorphismBiologyMicrobiologyPolymorphism Single NucleotideMycobacterium tuberculosisEvolution Molecular03 medical and health sciencesGenotypemedicineHumansTuberculosisAgedAged 80 and overTransmission (medicine)MicroevolutionGenetic VariationGeneral MedicineMycobacterium tuberculosisMiddle Agedbacterial infections and mycosesmedicine.diseasebiology.organism_classificationVirologyInfectious DiseasesFemaleInternational journal of medical microbiology : IJMM
researchProduct

Erratum for Yahav et al., "New β-Lactam-β-Lactamase Inhibitor Combinations".

2021

The limited armamentarium against drug-resistant Gram-negative bacilli has led to the development of several novel β-lactam–β-lactamase inhibitor combinations (BLBLIs). In this review, we summarize their spectrum of in vitro activities, mechanisms of resistance, and pharmacokinetic-pharmacodynamic (PK-PD) characteristics. A summary of available clinical data is provided per drug. Four approved BLBLIs are discussed in detail. All are options for treating multidrug-resistant (MDR) Enterobacterales and Pseudomonas aeruginosa. Ceftazidime-avibactam is a potential drug for treating Enterobacterales producing extended-spectrum β-lactamase (ESBL), Klebsiella pneumoniae carbapenemase (KPC), AmpC, a…

0301 basic medicineMicrobiology (medical)General Immunology and MicrobiologyCarbapenem resistantbiologyEpidemiologyChemistryStereochemistryKlebsiella pneumoniae030106 microbiologyPublic Health Environmental and Occupational HealthReviewbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycoses03 medical and health scienceschemistry.chemical_compound030104 developmental biologyInfectious Diseasesβ lactamase inhibitorLactampolycyclic compoundsbacteriaClinical microbiology reviews
researchProduct

Persistence of Two Non-Saccharomyces Yeasts (Hanseniaspora and Starmerella) in the Cellar

2016

International audience; Different genera and/or species of yeasts present on grape berries, in musts and wines are widely described. Nevertheless, the community of non-Saccharomyces yeasts present in the cellar is still given little attention. Thus it is not known if the cellar is a real ecological niche for these yeasts or if it is merely a transient habitat for populations brought in by grape berries during the winemaking period. This study focused on three species of non-Saccharomyces yeasts commonly encountered during vinification: Starmerella bacillaris (synonymy with Candida zemplinina), Hanseniaspora guilliermondii and Hanseniaspora uvarum. More than 1200 isolates were identified at …

0301 basic medicineMicrobiology (medical)Grape berriesCerevisiaeWine yeast[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition030106 microbiologyStarmerellalcsh:QR1-502StrainsCandida-stellataHanseniasporaMicrobiologySaccharomyceslcsh:MicrobiologyHanseniaspora03 medical and health sciences[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologycellarBotanyOriginal ResearchWinemakingDiversitybiologyfungifood and beveragespersistenceEnological propertiesbiology.organism_classificationSulfur-dioxideYeastCandida zemplininaYeast in winemaking[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologynon-Saccharomyces strainsStarmerellaHanseniaspora guilliermondiiAlcoholic fermentationPopulation-dynamicsFrontiers in Microbiology
researchProduct

A New Phylogenetic Framework for the Animal-adaptedMycobacterium tuberculosisComplex

2018

Tuberculosis (TB) affects humans and other animals and is caused by bacteria from the Mycobacterium tuberculosis complex (MTBC). Previous studies have shown that there are at least nine members of the MTBC infecting animals other than humans; these have also been referred to as ecotypes. However, the ecology and the evolution of these animal-adapted MTBC ecotypes are poorly understood. Here we screened 12,886 publicly available MTBC genomes and newly sequenced 17 animal-adapted MTBC strains, gathering a total of 529 genomes of animal-adapted MTBC strains. Phylogenomic and comparative analyses confirm that the animal-adapted MTBC members are paraphyletic with some members more closely relate…

0301 basic medicineMicrobiology (medical)Host–pathogen interactionsLineage (evolution)Populationlcsh:QR1-502specificityhost rangeHost tropismMicrobiologyGenetic diversitylcsh:Microbiology03 medical and health sciencesPhylogenomicseducationClade030304 developmental biologyWhole-genome sequencing0303 health scienceseducation.field_of_studybiologyPhylogenetic tree030306 microbiologygenetic diversitybiology.organism_classification3. Good health030104 developmental biologyhost–pathogen interactions; specificity; host range; genetic diversity; whole-genome sequencingMycobacterium tuberculosis complexwhole-genome sequencingEvolutionary biologyHost rangeSpecificityMycobacterium africanumhost–pathogen interactions
researchProduct

No effect of vancomycin MIC ≥ 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia

2018

International audience; The vancomycin minimum inhibitory concentration (MIC) has been shown to affect the outcome of methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia. In this study, the outcomes of patients with MSSA bacteraemia with a vancomycin MIC ≥ 1.5 mg/L were assessed. A prospective cohort of patients with MSSA bacteraemia in two tertiary-care hospitals was collected. The vancomycin MIC was determined by Etest. Staphylococcus aureus strains were categorised as low (<1.5 mg/L) or high (≥1.5 mg/L) vancomycin MIC. First- and second-line treatments were recorded and classified as optimal, appropriate and inappropriate. The primary endpoint was 30-day mortality. A total o…

0301 basic medicineMicrobiology (medical)MaleMethicillin-Resistant Staphylococcus aureusmedicine.medical_specialtyStaphylococcus aureusmedicine.drug_classmedicine.medical_treatment030106 microbiologyAntibioticsBacteremiaMicrobial Sensitivity Testsmedicine.disease_cause03 medical and health sciencesMinimum inhibitory concentrationVancomycin[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyInternal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologymedicineHumansPharmacology (medical)Prospective StudiesMortalityProspective cohort studyEtestDialysisAgedAged 80 and overMinimum inhibitory concentrationbusiness.industryGeneral MedicineMiddle AgedStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionbacterial infections and mycoses3. Good healthAnti-Bacterial Agents[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyInfectious DiseasesStaphylococcus aureusCatheter-Related InfectionsVancomycinBacteraemiaFemaleMethicillin Susceptible Staphylococcus Aureusbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Probiotic yeast Kluyveromyces marxianus CIDCA 8154 shows anti-inflammatory and anti-oxidative stress properties in in vivo models.

2015

Inflammatory bowel diseases (IBDs) are complex affections with increasing incidence worldwide. Multiple factors are involved in the development and maintenance of the symptoms including enhanced oxidative stress in intestinal mucosa. The conventional therapeutic approaches for IBDs are based on the use anti-inflammatory drugs with important collateral effects and partial efficacy. In the present work we tested the anti-inflammatory capacity of Kluyveromyces marxianus CIDCA 8154 in different models. In vitro, we showed that the pretreatment of epithelial cells with the yeast reduce the levels of intracellular reactive oxygen species. Furthermore, in a murine model of trinitro benzene sulfon…

0301 basic medicineMicrobiology (medical)Malemedicine.drug_class030106 microbiologyBiologymedicine.disease_causeMicrobiologyAnti-inflammatoryMicrobiologylaw.invention03 medical and health sciencesProbioticKluyveromycesMiceIntestinal mucosaKluyveromyces marxianusIn vivolawKluyveromycesmedicineAnimalsHumansCaenorhabditis eleganschemistry.chemical_classificationReactive oxygen speciesMice Inbred BALB CProbioticsAnti-Inflammatory Agents Non-Steroidalbiology.organism_classificationColitisOxidative StresschemistryCaco-2 CellsReactive Oxygen SpeciesHT29 CellsOxidative stressBeneficial microbes
researchProduct

Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.

2021

Abstract Objectives Gonococcal infection is one of the most reported sexually transmitted infections and antimicrobial resistance in Neisseria gonorrhoeae (NG) is challenging for the treatment of this infection. This observational study aimed to describe antimicrobial resistance of NG and epidemiological data from patients with gonococcal infection in eight regions of Spain, for updating the local therapeutic guidelines. Methods MICs of penicillin, cefixime, ceftriaxone, azithromycin, ciprofloxacin, fosfomycin and gentamicin were determined by Etest for all NG isolates recovered from 1 April 2018 to 30 September 2019 from 10 hospitals in Spain. Resistance determinants were identified using …

0301 basic medicineMicrobiology (medical)Malemedicine.medical_specialty030106 microbiologyMicrobial Sensitivity TestsFosfomycinAzithromycinAzithromycinmedicine.disease_cause03 medical and health sciencesGonorrheaSexual and Gender Minorities0302 clinical medicineAntibiotic resistanceCiprofloxacinInternal medicineDrug Resistance BacterialmedicineHumansPharmacology (medical)030212 general & internal medicineProspective StudiesHomosexuality MaleEtestPharmacologybusiness.industryCeftriaxoneNeisseria gonorrhoeaeAnti-Bacterial AgentsPenicillinCiprofloxacinInfectious DiseasesSpainNeisseria gonorrhoeaebusinessCefiximemedicine.drugThe Journal of antimicrobial chemotherapy
researchProduct